4-benzylcyclohexan-1-ol | 141191-74-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-benzylcyclohexan-1-ol
• 英文别名: trans-4-Benzylcyclohexan-1-ol；trans-4-benzylcyclohexanol；4-benzylcyclohexanol
• CAS: 141191-74-4
• 化学式: C₁₃H₁₈O
• 分子量: 190.285
• InChiKey: WOJJXJIOVRLFMD-JOCQHMNTSA-N

物化性质

• 沸点：
  305.4±11.0 °C(Predicted)
• 密度：
  1.046±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.78
• 重原子数：
  14.0
• 可旋转键数：
  2.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  20.23
• 氢给体数：
  1.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  4-benzylcyclohexan-1-ol 在 4-二甲氨基吡啶 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 31.0h， 生成 (4-benzylcyclohexyl) N-[(3S)-2-oxoazetidin-3-yl]carbamate
  参考文献：
  名称：

  [EN] CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS
  [FR] DÉRIVÉS DE CARBAMATE D'INHIBITEURS D'AMIDASE ACIDE DE N-ACYLÉTHANOLAMINE (NAAA) À BASE DE LACTAME

  摘要：

  公开号：

  WO2014144836A3
• 作为产物：
  描述：

  4-benzylidenecyclohexanol 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 以95%的产率得到4-benzylcyclohexan-1-ol
  参考文献：
  名称：

  [EN] CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS
  [FR] DÉRIVÉS DE CARBAMATE D'INHIBITEURS D'AMIDASE ACIDE DE N-ACYLÉTHANOLAMINE (NAAA) À BASE DE LACTAME

  摘要：

  公开号：

  WO2014144836A3

文献信息

• Rearrangement of Allylic and Propargylic Alcohols Catalyzed by the Combined Use of tetrabutylammonium perrhenate (VII) and p-toluenesulfonic acid
  作者：Koichi Narasaka、Hiroyuki Kusama、Yujiro Hayashi

  DOI：10.1016/s0040-4020(01)88874-8

  日期：1992.1

  Allylic rearrangement and/or dehydration reaction of allylic alcohols proceeds smoothly by the use of catalytic amounts of tetrabutylammonium perrhenate and p-toluenesulfonic acid hydrate. Treatment of propargylic alcohols with the catalysts at room temperature affords the rearranged products, α,β-unsaturated carbonyl compounds, while, β,γ-unsaturated ketones are obtained as main products by the reaction

  通过使用催化量的高丁基酸四丁铵和对甲苯磺酸水合物，使烯丙醇的烯丙基重排和/或脱水反应顺利进行。在室温下用催化剂处理炔丙醇可得到重排产物α，β-不饱和羰基化合物，而β，γ-不饱和酮是通过在1，2-二氯乙烷中回流反应得到的主要产物。还描述了该催化体系在某些合成中间体的制备中的应用。
• Perfume base composition
  申请人：Kao Corporation

  公开号：US05962403A1

  公开（公告）日：1999-10-05

  The present invention relates to a perfume base composition comprising a carrier and a benzyl-substituted cyclohexanol having formula (1), wherein the dashed line denotes an optional double bond and the benzyl group is in the 2-, 3- or 4-position of the cyclohexanol ring, with the proviso that the benzyl group is in the 4-position when a double bond is present in the cyclohexanol ring. The composition has not only a well-balanced fragrance but also excellent retentivity of fragrance.

  本发明涉及一种香水基础组合物，包括载体和具有式（1）的苯甲基取代的环己醇，其中虚线表示可选的双键，苯甲基在环己醇环的2-、3-或4-位上，但前提是当环己醇环中存在双键时，苯甲基在4-位上。该组合物不仅具有良好的香气平衡，而且具有优异的香气保留性。
• DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA)
  申请人：Fondazione Istituto Italiano Di Tecnologia

  公开号：US20160235707A1

  公开（公告）日：2016-08-18

  The present invention provides compounds and pharmaceutical compositions for inhibiting N-acylethanolamine acid amidase (NAAA). Inhibition of NAAA is contemplated as a method to sustain the levels of palmitoylethanolamide (PEA) and oleylethanolamide (OEA), two substrates of NAAA, in conditions characterized by reduced concentrations of PEA and OEA. The invention also provides methods for treating inflammatory diseases and pain, and other disorders in which decreased levels of PEA and OEA are associated with the disorder.

  本发明提供了用于抑制N-乙酰基乙醇胺酸酰化酶（NAAA）的化合物和制药组合物。抑制NAAA被认为是一种维持在PEA和OEA两种NAAA底物的水平在浓度降低的情况下的方法。本发明还提供了用于治疗炎症性疾病和疼痛以及其他与PEA和OEA水平下降相关的疾病的方法。
• CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS
  申请人：The Regents of the University of California

  公开号：US20160068482A1

  公开（公告）日：2016-03-10

  Described herein are compounds and pharmaceutical compositions which inhibit N-acylethanolamine acid amidase (NAAA). Described herein are methods for synthesizing the compounds set forth herein and methods for formulating these compounds as pharmaceutical compositions which include these compounds. Also described herein are methods of inhibiting NAAA in order to sustain the levels of palmitoylethanolamide (PEA) and other N-acylethanolamines (NAE) that are substrates for NAAA, in conditions characterized by reduced concentrations of NAE. Also, described here are methods of treating and ameliorating pain, inflammation, inflammatory diseases, and other disorders in which modulation of fatty acid ethanolamides is clinically or therapeutically relevant or in which decreased levels of NAE are associated with the disorder.

  本文描述了一些化合物和药物组成物，它们可以抑制N-酰基乙醇胺酸酰化酶（NAAA）。本文还描述了合成这些化合物的方法，以及将它们制成药物组成物的方法。同时，本文还描述了抑制NAAA以维持棕榈酰乙醇胺（PEA）和其他N-酰基乙醇胺（NAE）的水平的方法，这些物质是NAAA的底物，并且在NAE浓度降低的情况下有用。此外，本文还描述了治疗和缓解疼痛、炎症、炎症性疾病和其他疾病的方法，这些疾病中脂肪酸乙醇胺的调节在临床或治疗上是相关的，或者NAE的浓度降低与该疾病有关。
• A new paradigm for biohydroxylation by Beauveria bassiana ATCC 7159
  作者：Herbert L Holland、Terence A Morris、Phillip J Nava、Mirjana Zabic

  DOI：10.1016/s0040-4020(99)00393-2

  日期：1999.6

  The biohydroxylation of a series of amides and related amino, keto and hydrocarbon substrates by the fungal biocatalyst Beauveria bassiana ATCC 7159 has been examined. The product distributions, together with data obtained from selective inhibition experiments using the cyt.P-450 inhibitors isosafrole, 1-aminobenzotriazole and phenylacetylene, suggest that B. bassiana contains a range of hydroxylase enzymes with different substrate specificities. A paradigm is presented for the interpretation of the results of microbial hydroxylation and for the application of existing active site models for B. bassiana. (C) 1999 Elsevier Science Ltd. All rights reserved.